Effect of Dexmedetomidine on Preventing Agitation and Delirium after Microvascular Free Flap Surgery: A Randomized, Double-Blind, Control Study

Xudong Yang,Zhenzhen Li,Chunyan Gao,Ruichang Liu

DOI: https://doi.org/10.1016/j.joms.2015.01.011

IF: 1.9

2015-01-01

Journal of Oral and Maxillofacial Surgery

Abstract:Purpose: To determine whether dexmedetomidine sedation in the postanesthesia care unit (PACU) could decrease agitation and delirium after free flap surgery.Materials and Methods: Eighty patients were randomly divided into 2 groups. In the experimental group, dexmedetomidine was given at an hourly infusion rate of 0.5 mu g/kg for 1 hour before the operation was completed and continued in the PACU at 0.2 to 0.7 mu g/kg continuously until the next morning. In the control group, normal saline was given during the same periods. Patients in the 2 groups received sufentanil and midazolam for sedation and pain relief when necessary. Agitation was monitored with the Riker Sedation-Agitation Scale in the PACU and delirium was monitored with the Confusion Assessment Method for the Intensive Care Unit for 5 days postoperatively.Results: The overall incidence of agitation was similar between the 2 groups. However, when the influence of patient shiftingwas excluded, the incidence of agitation in the dexmedetomidine group was apparently lower than that in the control group (10.3 vs 30%; P =.029). No difference was found in the occurrence of delirium between the experimental and control groups (5.1 vs 12.5%; P =.432).Conclusion: Dexmedetomidine does not change the overall incidence of agitation after free flap surgery; however, it does decrease agitation after PACU admission. It does not prevent delirium within 5 days postoperatively. (C) 2015 American Association of Oral and Maxillofacial Surgeons